Lipocine (LPCN) Net Equity Issued and Repurchased (2011 - 2025)
Lipocine's Net Equity Issued and Repurchased came in at $141,334 for Q3 2025.
Powered by 
Analysis
Lipocine (LPCN) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Lipocine reported Net Equity Issued and Repurchased of $136,035, down 67.3% year-over-year; for FY2024, it came in at $209,340, down 48.3% from FY2023.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -48.2% (FY2019 to FY2024).
- Going back by year, Net Equity Issued and Repurchased was $404,567 in FY2023 (+91.4%), $211,423 in FY2022 (-99.2%), $26.84 million in FY2021 (+249.7%) and $7.67 million in FY2020 (+37.2%).
- The Q3 2025 figure represents the highest quarterly Net Equity Issued and Repurchased since Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 141,334.00 |
| Dec 31, 2023 | -5,299.00 |
| Sep 30, 2023 | 421,082.00 |
| Sep 30, 2022 | 5,344.00 |
| Jun 30, 2022 | 91.00 |
| Mar 31, 2022 | 205,988.00 |
| Mar 31, 2021 | 26.84 Mn |
| Dec 31, 2020 | -25,124.00 |
| Sep 30, 2020 | 761,000.00 |
| Jun 30, 2020 | 6.90 Mn |
| Mar 31, 2020 | 5.65 Mn |
| Dec 31, 2019 | 5.54 Mn |
| Sep 30, 2019 | 56,200.00 |
| Jun 30, 2019 | -6.06 Mn |
| Mar 31, 2019 | 6.06 Mn |
| Dec 31, 2018 | 561,334.00 |
| Sep 30, 2018 | 91,000.00 |
| Sep 30, 2017 | 2.30 Mn |
| Jun 30, 2017 | 5.70 Mn |
| Mar 31, 2017 | 2.70 Mn |
API Access
Lipocine Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();